BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 439009)

  • 1. Comparison of the activity of the cis and trans isomer of vitamin K1 in vitamin K-deficient and coumarin anticoagulant-pretreated rats.
    Lowenthal J; Vergel Rivera GM
    J Pharmacol Exp Ther; 1979 Jun; 209(3):330-3. PubMed ID: 439009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopotency of vitamin K. I. Antihemorrhagic properties of structural analogs of phylloquinone as determined by curative prothrombin time tests.
    Weiser H; Kormann AW
    Int J Vitam Nutr Res; 1983; 53(2):143-55. PubMed ID: 6885274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the thyroid function on the metabolic rate of prothrombin, factor VII, and factor X in the rat.
    van Oosterom AT; Mattie H; Hermens WT; Veltkamp JJ
    Thromb Haemost; 1976 Jun; 35(3):607-19. PubMed ID: 989968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K deficiency amplifies anticoagulation response to ximelagatran: possible implications for direct thrombin inhibitors and their clinical safety.
    Kamali F; Wood P; Ward A
    Ann Hematol; 2009 Feb; 88(2):141-9. PubMed ID: 18716776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K requirement in Danish anticoagulant-resistant Norway rats (Rattus norvegicus).
    Markussen MD; Heiberg AC; Nielsen R; Leirs H
    Pest Manag Sci; 2003 Aug; 59(8):913-20. PubMed ID: 12916772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K and coumarin anticoagulants: dependence of anticoagulant effect on inhibition of vitamin K transport.
    Lowenthal J; Birnbaum H
    Science; 1969 Apr; 164(3876):181-3. PubMed ID: 5774189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cis astaxanthin and especially 9-cis astaxanthin exhibits a higher antioxidant activity in vitro compared to the all-trans isomer.
    Liu X; Osawa T
    Biochem Biophys Res Commun; 2007 May; 357(1):187-93. PubMed ID: 17416351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of competitive vitamin K antagonist, 2-chloro-3-phytyl-1,4-naphthoquinone, for the study of the mechanism of action of vitamin K and coumarin anticoagulants.
    Lowenthal J; MacFarlane JA
    J Pharmacol Exp Ther; 1967 Sep; 157(3):672-80. PubMed ID: 6048023
    [No Abstract]   [Full Text] [Related]  

  • 9. A plasma factor enhances activity of vitamin K-dependent coagulation proteins.
    Owens MR; Cimino CD
    Thromb Haemost; 1983 Oct; 50(3):749-52. PubMed ID: 6648895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of warfarin, phenylindanedione, tetrachloropyridinol, and chloro-vitamin K1 on prothrombin synthesis and vitamin K metabolism in normal and warfarin-resistant rats.
    Ren P; Laliberte RE; Bell RG
    Mol Pharmacol; 1974 May; 10(3):373-80. PubMed ID: 4851787
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioactivity of cis and dicis isomers of vitamin A esters.
    Weiser H; Somorjai G
    Int J Vitam Nutr Res; 1992; 62(3):201-8. PubMed ID: 1473900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The absorption and bioactivity of bacterially synthesized menaquinones.
    Conly JM; Stein KE
    Clin Invest Med; 1993 Feb; 16(1):45-57. PubMed ID: 8467580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary vitamin K1 and stability of oral anticoagulation: proposal of a diet with constant vitamin K1 content.
    Booth SL; Charnley JM; Sadowski JA; Saltzman E; Bovill EG; Cushman M
    Thromb Haemost; 1997 Mar; 77(3):504-9. PubMed ID: 9066002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats.
    Yamanaka Y; Yamano M; Yasunaga K; Shike T; Uchida K
    Thromb Res; 1990 Jan; 57(2):205-14. PubMed ID: 2315885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatographic determination of vitamin K1 trans- and cis-isomers in infant formula.
    Hwang SM
    J Assoc Off Anal Chem; 1985; 68(4):684-9. PubMed ID: 4030639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose - response relationship between warfarin and the metabolism of phylloquinone (vitamin K1) in man.
    Shearer MJ; McBurney A; Breckenridge A; Barkhan P
    Int J Vitam Nutr Res; 1976; 46(2):215-9. PubMed ID: 1032634
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study on changes of serum vitamin K1 level and K dependent coagulation factors in patients with coumarin derivatives (warfarin) therapy].
    Suzuki K; Shimazu C; Yasuda K
    Rinsho Byori; 1992 Jul; 40(7):783-8. PubMed ID: 1507498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K1 increases sister chromatid exchange in vitro in human leukocytes and in vivo in fetal sheep cells: a possible role for "vitamin K deficiency" in the fetus.
    Israels LG; Friesen E; Jansen AH; Israels ED
    Pediatr Res; 1987 Oct; 22(4):405-8. PubMed ID: 3684371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of vitamin K1 and warfarin on prothrombin expression in human hepatoblastoma (HepG2) cells.
    Jamison CS; Burkey BF; Degen SJ
    Thromb Haemost; 1992 Jul; 68(1):40-7. PubMed ID: 1325077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of warfarin on the kinetics of the vitamin K-dependent clotting factors in rats.
    Vainieri H; Wingard LB
    J Pharmacol Exp Ther; 1977 May; 201(2):507-17. PubMed ID: 870684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.